APAC Contraceptives Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.39 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
APAC Contraceptives Market Analysis
The Asia-Pacific contraceptive drugs and devices market is anticipated to record a CAGR of 6.39%, during the forecast period. The major factors attributing to the growth of the Asia-Pacific contraceptive drugs and devices market include the necessity to avoid unwanted pregnancies and their complications. The need to avoid unwanted pregnancies, especially in teenage women, is one of the major drivers for this market. It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population in the region.
APAC Contraceptives Market Trends
This section covers the major market trends shaping the APAC Contraceptives Market according to our research experts:
Oral Contraceptive Segment is Expected to Hold the Largest Market Share in the Asia-Pacific Contraceptive Market
Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across the region by companies, and thus, easily consumed by a large section of the population, regionally. These factors are expected to contribute to the growth of the market during the forecast period.
APAC Contraceptives Industry Overview
The Asia-Pacific contraceptive market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the region. Some of the companies that are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co. Inc., CooperSurgical Inc., and Allergan PLC.
APAC Contraceptives Market Leaders
Bayer AG
Pfizer Inc.
Merck & Co., Inc.
CooperSurgical, Inc.
Allergan PLC
*Disclaimer: Major Players sorted in no particular order
APAC Contraceptives Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Incidence of the STDs
-
4.2.2 Increasing Rate of Unintended Pregnancies
-
4.2.3 Rise in Government Initiatives
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Devices and Treatment
-
4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product
-
5.1.1 By Drugs
-
5.1.1.1 Oral Contraceptives
-
5.1.1.2 Topical Contraceptives
-
5.1.1.3 Contraceptive Injectable
-
-
5.1.2 By Device
-
5.1.2.1 Condoms
-
5.1.2.2 Diaphragms
-
5.1.2.3 Cervical Caps
-
5.1.2.4 Sponges
-
5.1.2.5 Vaginal Rings
-
5.1.2.6 IUD
-
5.1.2.7 Other Devices
-
-
-
5.2 By Gender
-
5.2.1 Male
-
5.2.2 Female
-
-
5.3 Geography
-
5.3.1 Asia-Pacific
-
5.3.1.1 China
-
5.3.1.2 Japan
-
5.3.1.3 India
-
5.3.1.4 Australia
-
5.3.1.5 South korea
-
5.3.1.6 Rest of Asia-Pacific
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Bayer AG
-
6.1.2 Pfizer Inc.
-
6.1.3 Merck & Co. Inc.
-
6.1.4 CooperSurgical Inc.
-
6.1.5 Allergan PLC
-
6.1.6 Johnson & Johnson Ltd
-
6.1.7 Lupin Pharmaceuticals Ltd
-
6.1.8 Mylan Laboratories
-
6.1.9 Church & Dwight Co. Inc.
-
6.1.10 The Female Health Company
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
APAC Contraceptives Industry Segmentation
In basic terms, contraceptives refer to a set of devices, methods, medications, and techniques that are used to control births. The use of contraceptive pills, hormonal IUD, copper IUD, condoms, diaphragm, injections, and cervical cap are some commonly used contraceptive methods.
| By Product | |||||||||
| |||||||||
|
| By Gender | |
| Male | |
| Female |
| Geography | ||||||||
|
APAC Contraceptives Market Research FAQs
What is the current Asia-Pacific Contraceptive Drugs and Devices Market size?
The Asia-Pacific Contraceptive Drugs and Devices Market is projected to register a CAGR of 6.39% during the forecast period (2024-2029)
Who are the key players in Asia-Pacific Contraceptive Drugs and Devices Market?
Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical, Inc. and Allergan PLC are the major companies operating in the Asia-Pacific Contraceptive Drugs and Devices Market.
What years does this Asia-Pacific Contraceptive Drugs and Devices Market cover?
The report covers the Asia-Pacific Contraceptive Drugs and Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Contraceptive Drugs and Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia-Pacific Contraceptive Drugs and Devices Industry Report
Statistics for the 2024 Asia-Pacific Contraceptive Drugs and Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Contraceptive Drugs and Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
